外阴转移性癌60例临床分析  

Clinical Analysis of 60 Cases with Metastatic Carcinoma of Vulva

作　　者：陈洁[1] 孙敏[1] 张志毅[1] 

机构地区：[1]上海医科大学肿瘤医院,上海200032

出　　处：《浙江肿瘤》2000年第4期197-198,共2页

摘　　要：〔目的〕探讨外阴转移性癌的诊断和治疗。〔方法〕对60例外阴转移性癌临床资料进行回顾性分析。〔结果〕60例外阴转移性癌 ,主要继发于宫颈癌和宫体癌 ,3年、5年生存率分别为30 15%和20 10 %。综合治疗5年生存率(手术加化疗24 10 %、放疗加化疗18 60 %)明显优于单纯化疗(10 96 %)和单纯放疗(14 54%)。转移灶大于2cm或多发或伴有原发肿瘤复发/远处转移者生存率较差。〔结论〕外阴转移性癌预后差 ,综合治疗可提高生存率从而延长生命。睵urpose〕To investigate the diagnosis and treatment of metastatic carcinoma of vulva.〔Methods〕Clinical data of 60 cases with metastatic carcinoma of vulva were retrospectively analyzed.〔Results〕60 patients with metastatic carcinoma of vulva,which were mainly secondary to cervical cancer or endometrial carcinoma,were treated and followed up.The 3-year and 5-year survival rates were 30.15% and 20.10%.The 5-year survival rate of multimodality therapy (surgery and chemotherapy 24.10%,radiochemotherapy 18.60%)was significantly higher than that of chemotherapy (10.96%) or radiotherapy(14.54%) alone.Those patients whose metastatic lesion was bigger than 2cm or multiple or accompanied by recurrence or other distant metastasis of primary tumor had worse survival rate.〔Conclusion〕The patients with metastatic carcinoma of vulva have a poor prognosis.Multimodality therapy can increase the survival rate and prolong survival.

关 键 词：外阴肿瘤 肿瘤转移 综合疗法 预后 

分 类 号：R737.35[医药卫生—肿瘤]